Effects of Intensive Glucose Lowering in Type 2 Diabetes is a research paper published in New England Journal of Medicine (2008). On theSindex it has a DataRank of 1.3. It has been cited 7,857 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.3
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: N01-HC-95179
NHLBI NIH HHS
Grant: N01-HC-95183
NHLBI NIH HHS
Grant: N01-HC-95182
NHLBI NIH HHS
Grant: N01 HC095184
NHLBI NIH HHS
Grant: Y01 HC001010
NHLBI NIH HHS
Grant: IAA-Y1-HC-1010
NHLBI NIH HHS
Grant: N01 HC095179
NHLBI NIH HHS
Grant: N01 HC095181
NHLBI NIH HHS
Grant: N01 HC095182
NHLBI NIH HHS
Grant: N01-HC-95181
NHLBI NIH HHS
Grant: N01 HC095180
NHLBI NIH HHS
Grant: IAA-Y1-HC-9035
NHLBI NIH HHS
Grant: N01 HC095178
NHLBI NIH HHS
Grant: N01-HC-95184
NHLBI NIH HHS
Grant: N01-HC-95178
NINR NIH HHS
Grant: P30 NR005035
NHLBI NIH HHS
Grant: Y01 HC009035
NHLBI NIH HHS
Grant: N01 HC095183
NHLBI NIH HHS
Grant: N01-HC-95180
MeSH Terms
Additional file 5 of The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Additional file 5 of The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Additional file 2 of The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Additional file 2 of The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Additional file 1 of The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Additional file 1 of The effects of different doses of exercise on pancreatic β-cell function in patients with newly diagnosed type 2 diabetes: study protocol for and rationale behind the “DOSE-EX” multi-arm parallel-group randomised clinical trial
Additional file 2 of Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
Additional file 2 of Associations between continuous glucose monitoring-derived metrics and arterial stiffness in Japanese patients with type 2 diabetes
Additional file 1 of How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool
Additional file 1 of How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool
Additional file 1 of Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
Additional file 1 of Waist circumference is associated with major adverse cardiovascular events in male but not female patients with type-2 diabetes mellitus
Additional file 1 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 1 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 2 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 2 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 3 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 3 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 4 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study
Additional file 4 of The sweet spot: fasting glucose, cardiovascular disease, and mortality in older adults with diabetes: a nationwide population-based study